Correlation of beta-catenin localization with cyclooxygenase-2 expression and CpG island methylator phenotype (CIMP) in colorectal cancer.
about
Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and diseaseMolecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary fieldLifestyle factors and microsatellite instability in colorectal cancer: the evolving field of molecular pathological epidemiologyDifferences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancerNeoplasia: the second decade.SerpinB3 upregulates the Cyclooxygenase-2 / β-Catenin positive loop in colorectal cancerComprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based samplePrognostic Significance of β-Catenin, E-Cadherin, and SOX9 in Colorectal Cancer: Results from a Large Population-Representative Series.PTGER2 overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype.A prospective cohort study shows unique epigenetic, genetic, and prognostic features of synchronous colorectal cancers.DNMT3B expression might contribute to CpG island methylator phenotype in colorectal cancerA cohort study of STMN1 expression in colorectal cancer: body mass index and prognosis.Epigenomic diversity of colorectal cancer indicated by LINE-1 methylation in a database of 869 tumors.NRAS mutations are rare in colorectal cancer.Prognostic significance of CDKN2A (p16) promoter methylation and loss of expression in 902 colorectal cancers: Cohort study and literature review.Novel application of structural equation modeling to correlation structure analysis of CpG island methylation in colorectal cancerCDK8 expression in 470 colorectal cancers in relation to beta-catenin activation, other molecular alterations and patient survival.STAT3 expression, molecular features, inflammation patterns, and prognosis in a database of 724 colorectal cancersAssociation of CTNNB1 (beta-catenin) alterations, body mass index, and physical activity with survival in patients with colorectal cancer.Cancer immunology--analysis of host and tumor factors for personalized medicine.Helicobacter pylori promotes angiogenesis depending on Wnt/beta-catenin-mediated vascular endothelial growth factor via the cyclooxygenase-2 pathway in gastric cancer.IGFBP3 promoter methylation in colorectal cancer: relationship with microsatellite instability, CpG island methylator phenotype, and p53.Molecular classification and correlates in colorectal cancerSurvival Benefit of Exercise Differs by Tumor IRS1 Expression Status in Colorectal Cancer.Differential WNT activity in colorectal cancer confers limited tumorigenic potential and is regulated by MAPK signalingPIK3CA mutation in colorectal cancer: relationship with genetic and epigenetic alterations.Prospective analysis of body mass index, physical activity, and colorectal cancer risk associated with β-catenin (CTNNB1) status.Associations of beta-catenin alterations and MSI screening status with expression of key cell cycle regulating proteins and survival from colorectal cancerPrognostic Utility of Molecular Factors by Age at Diagnosis of Colorectal Cancer.JC virus T-antigen in colorectal cancer is associated with p53 expression and chromosomal instability, independent of CpG island methylator phenotype.Combined aberrant expression of E-cadherin and S100A4, but not β-catenin is associated with disease-free survival and overall survival in colorectal cancer patientsColorectal cancer expression of peroxisome proliferator-activated receptor gamma (PPARG, PPARgamma) is associated with good prognosisCpG island tumor suppressor promoter methylation in non-BRCA-associated early mammary carcinogenesisAurora-A expression is independently associated with chromosomal instability in colorectal cancer.CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer.Aberrant crypt foci as precursors in colorectal cancer progression.SIRT1 histone deacetylase expression is associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer.CpG methylation analysis--current status of clinical assays and potential applications in molecular diagnostics: a report of the Association for Molecular Pathology.Cyclin D1 is frequently overexpressed in microsatellite unstable colorectal cancer, independent of CpG island methylator phenotype.Sex differences in the prognostic significance of KRAS codons 12 and 13, and BRAF mutations in colorectal cancer: a cohort study.
P2860
Q24289344-2AE5424A-9F95-444D-8306-B9B8C9B50339Q24620628-F6D44D20-2322-490B-9503-6525704C730EQ24622814-B17801B3-FCC9-4983-8DAC-C4E5865C9CE6Q28239338-897C508B-1B15-4B11-81DA-9BD5F843412BQ30484000-FE1984CA-0A4C-4A69-BC3F-5EA5CB178960Q30842687-54D51920-4BC9-42EE-A9F2-5B8CB6887246Q33383866-A5A3A415-1AF5-470E-8D19-C263293029C4Q33659798-3C6BCD31-00CD-4433-A597-DA4EDD59432DQ33723499-FE94BE79-C683-45D7-8769-BD5847B33EF2Q33808550-4C6D2C24-F771-49EA-9D87-BF210D78B942Q33837632-1FAF18B0-28DF-4D8B-88B7-C7D9D898A448Q33837712-6E790DF5-647F-4AE7-8BAF-A430FD7E267BQ33942280-3BA8504B-1174-44BE-B688-07D6FC1EB9EAQ34091172-20B9B8A1-2544-47FD-AF3D-5AE5AAA92370Q34217637-69C07B16-E0BF-488A-8C40-A2ACFB134942Q34358286-22959E2E-317F-4F52-9BCE-AA833EDFBEF8Q34561921-E44BFED7-7044-4F16-A5BD-750E78D3385FQ34796500-E893C8C6-4EC9-49E1-9054-98DEE69DF20BQ34921255-F04D0EFC-2AFC-4BA3-968C-DF2B318FA5F7Q35583180-3CACADC8-FB87-4904-91C9-9C6D0987029FQ36023196-291FE6E2-B90D-4941-B489-ECAC4A3E799AQ36259638-BE594FCF-0FE8-423E-808E-512DF583DA82Q36329300-B9C7F6C4-6BEC-46B4-9986-D7AB2A149EB9Q36563705-BD489907-6367-4EC7-B30C-DF749B580806Q36606380-701D595C-9BDB-4D92-B790-B5AB6E01F1A6Q36661711-6E908A65-9188-4BC0-853B-A4593B738115Q36675320-4E622D43-6D7C-44FC-B5F0-8F9E30202965Q36689001-3989F0E4-452D-45B6-A1BA-B3E3655D3F8DQ36954147-05138367-A12F-46F2-8DAD-1C277A529345Q37021811-54199542-B835-4C3D-9206-0F75BAF8071AQ37057045-463AA61B-AEAD-4E8E-BDED-5C74246DD9FBQ37146010-DE3F2415-0BC9-4CA9-B4E5-CDF5AC110216Q37155719-B0355EAA-E56E-4FA5-838B-A3DFF012B8C1Q37165838-CAB87F13-0021-4949-A90E-80EC17279C8FQ37185561-0BDC00E6-D1E9-471C-BA76-AE10EEEF24BAQ37214832-102362A8-9307-4263-A73F-B7F9FA04F2ADQ37246556-30A98FDC-3DF0-4DE3-95BD-C1EB2A20D426Q37261842-0A60F5A1-7957-4DEE-BCC2-54866365AD41Q37286815-680C6B20-56D1-40D9-8166-2CF04525D197Q37355802-C76E74BF-B59C-49C7-AE39-01D7D2C02EE0
P2860
Correlation of beta-catenin localization with cyclooxygenase-2 expression and CpG island methylator phenotype (CIMP) in colorectal cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Correlation of beta-catenin lo ...... e (CIMP) in colorectal cancer.
@ast
Correlation of beta-catenin lo ...... e (CIMP) in colorectal cancer.
@en
type
label
Correlation of beta-catenin lo ...... e (CIMP) in colorectal cancer.
@ast
Correlation of beta-catenin lo ...... e (CIMP) in colorectal cancer.
@en
prefLabel
Correlation of beta-catenin lo ...... e (CIMP) in colorectal cancer.
@ast
Correlation of beta-catenin lo ...... e (CIMP) in colorectal cancer.
@en
P2093
P2860
P356
P1433
P1476
Correlation of beta-catenin lo ...... e (CIMP) in colorectal cancer.
@en
P2093
Gregory J Kirkner
Katsuhiko Nosho
Mutsuko Ohnishi
Reiko Dehari
Shuji Ogino
Takako Kawasaki
Yuko Suemoto
P2860
P304
P356
10.1593/NEO.07334
P577
2007-07-01T00:00:00Z